Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: Involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 637-644

  Lu, Xin Lan ^a   He, Shui Xiang ^a   Ren, Mu Dan ^a   Wang, Yan Li ^a   Zhang, Ya Xin ^a   Liu, En Qi ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

CCAAT enhancer binding protein ; Cyclooxygenase 2; Diethylinitrosamine; Hepatocellular carcinoma; Saikosaponin d

Indexed keywords

ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 2; SAIKOSAPONIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER NODULE; MACROPHAGE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TUMOR CELL;

ANIMALS; BUPLEURUM; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHEMOPREVENTION; CYCLOOXYGENASE 2; DIETHYLNITROSAMINE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; OLEANOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS;

APIACEAE; BUPLEURUM FALCATUM; RATTUS;

EID: 84863018491     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.702     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Villanueva A and Llovet JM: Targeted therapies for hepato cellular carcinoma. Gastroenterology 140: 1410-1426, 2011.
3. Sherman M: Hepatocellular carcinoma: New and emerging risks. Dig Liver Dis 42: S215-S222, 2010.
4. Williams CS, Mann M and DuBois RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999. (Pubitemid 30066236)
5. Colby JK, Klein RD, McArthur MJ, et al: Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia 10: 782-796, 2008.
6. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, et al: The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110: 1831-1838, 2002.
7. Rahman MA, Dhar DK, Yamaguchi E, et al: Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 7: 1325-1332, 2001. (Pubitemid 32708688)
8. Sivaramakrishnan V and Niranjali Devaraz S: Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Interact 180: 353-359, 2009.
9. Giannitrapani L, Ingrao S, Soresi M, et al: Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study. Ann NY Acad Sci 1155: 293-299, 2009.
10. Koga H, Sakisaka S, Ohishi M, et al: Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29: 688-696, 1999. (Pubitemid 29109581)
11. Yoshida K, Tanaka T, Kohno H, et al: A COX-2 inhibitor, nimesulide, inhibits chemically-induced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression. Histol Histopathol 18: 39-48, 2003. (Pubitemid 36040446)
12. Banerjee S, Bueso-Ramos C and Aggarwal BB: Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62: 4945-4954, 2002. (Pubitemid 34984418)
13. Nagahara T, Okano J, Fujise Y, Abe R and Murawaki Y: Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats. Biomed Pharmacother 64: 319-326, 2010.
14. Ramji DP and Foka P: CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575, 2002. (Pubitemid 34864439)
15. Pal R, Janz M, Galson DL, et al: C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. Blood 114: 3890-3898, 2009.
16. Zhu S, Yoon K, Sterneck E, Johnson PF and Smart RC: CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 99: 207-212, 2002. (Pubitemid 34060342)
17. Buck M, Poli V, Hunter T and Chojkier M: C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 8: 807-816, 2001. (Pubitemid 33030214)
18. Connors SK, Balusu R, Kundu CN, Jaiswal AS, Gairola CG and Narayan S: C/EBPbeta-mediated transcriptional regulation of bcl-xl gene expression in human breast epithelial cells in response to cigarette smoke condensate. Oncogene 28: 921-932, 2009.
19. Gustafson TL, Wellberg E, Laffin B, et al: Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta. Oncogene 28: 1561-1568, 2009.
20. Luedde T, Duderstadt M, Streetz KL, et al: C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 40: 356-365, 2004. (Pubitemid 39062853)
21. Buck M, Poli V, van der Geer P, Chojkier M and Hunter T: Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol Cell 4: 1087-1092, 1999. (Pubitemid 30054914)
22. Buck M and Chojkier M: A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis. PLoS One 2: e1372, 2007.
23. Gorgoni B, Caivano M, Arizmendi C and Poli V: The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J Biol Chem 276: 40769-40777, 2001.
24. Regalo G, Canedo P, Suriano G, et al: C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression. J Pathol 210: 398-404, 2006. (Pubitemid 44830599)
25. Yue X, Yang F, Yang Y, et al: Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter. Virol J 8: 118, 2011.
26. Cieslik K, Zhu Y and Wu KK: Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer- binding protein-beta binding via a common signaling pathway. J Biol Chem 277: 49304-49310, 2002. (Pubitemid 36014360)
27. Saunders MA, Sansores-Garcia L, Gilroy DW and Wu KK: Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J Biol Chem 276: 18897-18904, 2001.
28. Guinea MC, Parellada J, Lacaille-Dubois MA and Wagner H: Biologically active triterpene saponins from Bupleurum fruticosum. Planta Med 60: 163-167, 1994. (Pubitemid 24120904)
29. Hsu YL, Kuo PL and Lin CC: The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci 75: 1231-1242, 2004.
30. Hsu YL, Kuo PL, Chiang LC and Lin CC: Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Lett 213: 213-221, 2004.
31. Bermejo Benito P, Abad Martinez MJ, Silvan Sen AM, et al: In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci 63: 1147-1156, 1998. (Pubitemid 29369120)
32. Fan J, Li X, Li P, et al: Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury. Biochem Cell Biol 85: 189-195, 2007. (Pubitemid 46841687)
33. 4-induced hepatic fibrogenesis in rats. World J Gastroenterol 13: 557-563, 2007.
34. Liang X, Hu YN, He SX, et al: Significance of COX-2 and C/EBPβ expression in hepatocellular carcinoma. World Chin J Digestol 18: 3040-3044, 2010.
35. He SX, Luo JY, Zhao G, et al: Effect of saikosaponins-d on cyclooxygenase-2 expression of human hepatocellular carcinoma cell line SMMC-7721. Zhonghua Gan Zang Bing Za Zhi 14: 712-714, 2006 (In Chinese).
36. Newell P, Villanueva A, Friedman SL, Koike K and Llovet JM: Experimental models of hepatocellular carcinoma. J Hepatol 48: 858--879, 2008.
37. Schneider-Merck T, Borbath I, Charette N, et al: The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats. Eur J Cancer 45: 2050-2060, 2009.
38. Zeng J, Sun Y, Wu K, et al: Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria. Mol Cancer Ther 10: 104-116, 2011.
39. Yu J, Wu CW, Chu ES, et al: Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice. Biochem Biophys Res Commun 372: 571-577, 2008.
40. Rask K, Thorn M, Ponten F, et al: Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 86: 337-343, 2000. (Pubitemid 30187493)
41. Sundfeldt K, Ivarsson K, Carlsson M, et al: The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer 79: 1240-1248, 1999. (Pubitemid 29087905)
42. Bundy LM and Sealy L: CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22: 869-883, 2003. (Pubitemid 36255823)
43. Thomas B, Berenbaum F, Humbert L, et al: Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes. Eur J Biochem 267: 6798-6809, 2000.
44. Wu KK, Liou JY and Cieslik K: Transcriptional control of COX-2 via C/EBPbeta. Arterioscler Thromb Vasc Biol 25: 679-685, 2005. (Pubitemid 40463853)
45. Wang W, Bergh A and Damber JE: Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate 67: 1238-1246, 2007. (Pubitemid 47221891)
46. Breinig M, Schirmacher P and Kern MA: Cyclooxygenase-2 (COX-2)-a therapeutic target in liver cancer? Curr Pharm Des 13: 3305-3315, 2007. (Pubitemid 350201686)
47. Wong VK, Zhou H, Cheung SS, Li T and Liu L: Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. J Cell Biochem 107: 303-315, 2009.